Literature DB >> 8137287

Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V-79 and HeLa cells.

C Hennequin1, N Giocanti, J Balosso, V Favaudon.   

Abstract

Interaction between gamma-rays and camptothecin (CPT) was investigated in vitro, using log phase HeLa-S3 cells and Chinese hamster V-79 fibroblasts. A plateau of toxicity was rapidly reached for both cell lines upon exposure to CPT alone, consistent with S-phase specificity of CPT. With synchronized HeLa cells, however, CPT proved cytotoxic after the middle of G1 phase. This effect was abolished by cotreatment with the DNA polymerase alpha inhibitor aphidicolin. CPT enhanced the initial slope of the radiation survival curves for asynchronous cells by a factor of 1.1 (HeLa) to 2.3 (V-79). This apparent radiation sensitization correlated with the intrinsic radiosensitivities of the drug-surviving fractions within the different compartments of the cell cycle. There was no evidence of mutual potentiation of CPT and radiation in terms of survival as well as with regard to the formation and rejoining of DNA double-strand breaks. V-79 cells exhibited pronounced postirradiation recovery. In contrast, the response of HeLa cells to drug did not vary appreciably for over 8-h following radiation. This difference proceeded from differential cell cycle redistribution. In both cell lines, acute irradiation produced depletion of the G1 compartment, accumulation at the S-G2 junction, and G2 arrest in proportion to the gamma-ray dose. However, while radiation brought about rapid depletion of the S-phase compartment in V-79 cells, it induced accumulation of HeLa cells into S phase. As a result, the CPT-sensitive HeLa cell population, consisting of the early-S, mid-S, and late G1 fractions, did not vary very much after irradiation. Exposure to CPT under conditions of low dose rate irradiation (1 Gy/h) selectively reversed the radiation effect on S-phase progression in V-79 cells; i.e., it induced accumulation of cells in S phase in the same way as found with HeLa cells. Isobolic analysis of survival data consistently showed supraadditivity of cell killing in both cell lines upon concomitant exposure to CPT and low dose rate irradiation. Cytokinetic cooperation appears to be the major determinant of cell survival in treatments associating CPT and radiation in growing cells. Attempts to predict the outcome of such a combined modality thus should take into consideration the response of the growing fraction of each cell line in terms of cell cycle-regulatory processes and redistribution.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137287

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Contribution of topoisomerase I to conversion of single-strand into double-strand DNA breaks.

Authors:  B Kowalska-Loth; I Bubko; B Komorowska; I Szumiel; K Staron
Journal:  Mol Biol Rep       Date:  1998-01       Impact factor: 2.316

2.  Modulation of the effect of camptothecin in x-irradiated L5178Y-R and L5178Y-S cells by benzamide.

Authors:  I Gradzka; T Iwaneńko; M Kruszewski; I Szumiel; M Kapiszewska; C S Lange; G Afanasjev
Journal:  Radiat Environ Biophys       Date:  1996-08       Impact factor: 1.925

Review 3.  Emerging drug treatments for solid tumours.

Authors:  J H Schellens; L C Pronk; J Verweij
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

4.  DNA damage triggers Golgi dispersal via DNA-PK and GOLPH3.

Authors:  Suzette E Farber-Katz; Holly C Dippold; Matthew D Buschman; Marshall C Peterman; Mengke Xing; Christopher J Noakes; John Tat; Michelle M Ng; Juliati Rahajeng; David M Cowan; Greg J Fuchs; Huilin Zhou; Seth J Field
Journal:  Cell       Date:  2014-01-30       Impact factor: 41.582

Review 5.  PET/CT Imaging and Radioimmunotherapy of Prostate Cancer.

Authors:  Kirsten Bouchelouche; Scott T Tagawa; Stanley J Goldsmith; Baris Turkbey; Jacek Capala; Peter Choyke
Journal:  Semin Nucl Med       Date:  2011-01       Impact factor: 4.446

6.  Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak.

Authors:  W L Marshall; C Yim; E Gustafson; T Graf; D R Sage; K Hanify; L Williams; J Fingeroth; R W Finberg
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  The potential of topoisomerase I inhibitors in the treatment of CNS malignancies: report of a synergistic effect between topotecan and radiation.

Authors:  J P Lamond; M P Mehta; D A Boothman
Journal:  J Neurooncol       Date:  1996-10       Impact factor: 4.130

8.  Protein oxidation and DNA repair inhibition by 6-thioguanine and UVA radiation.

Authors:  Quentin Gueranger; Feng Li; Matthew Peacock; Annabel Larnicol-Fery; Reto Brem; Peter Macpherson; Jean-Marc Egly; Peter Karran
Journal:  J Invest Dermatol       Date:  2013-11-27       Impact factor: 8.551

9.  Topoisomerase IIalpha-dependent induction of a persistent DNA damage response in response to transient etoposide exposure.

Authors:  Sébastien Soubeyrand; Louise Pope; Robert J G Haché
Journal:  Mol Oncol       Date:  2009-10-09       Impact factor: 6.603

10.  Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity.

Authors:  Rodger E Tiedemann; Xinliang Mao; Chang-Xin Shi; Yuan Xiao Zhu; Stephen E Palmer; Michael Sebag; Ron Marler; Marta Chesi; Rafael Fonseca; P Leif Bergsagel; Aaron D Schimmer; A Keith Stewart
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.